IMRN | Immuron
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a microbiome company focused on developing and commercialising oral immunotherapeutics for the treatment of many gut mediated diseases. Immuron has a unique and safe technology platform that enables a shorter development therapeutic cycle.
About the Company
Anadis is a biotechnology company based in Melbourne, Australia. In 2008 Anadis changed its name to Immuron Ltd. The company focused on antigen-primed, dairy-derived health products.
Building 10, 25-37 Chapman Street, Blackburn North, VIC 3131 Australia
Products & Services
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
Buy on Amazon
Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.